Formulation and Delivery - Chemical - Formulation

(T0930-01-02) A Physical Picture for the Dissolution Process of Copovidone ASDs

(M0930-01-04) Role of Propylene Glycol in the Transdermal Permeation of Clobetasol

(W0930-01-04) Spray Drying Versus Coprecipitation for Processing Amorphous Solid Dispersions

(W0930-01-05) Impact of Spray-Dried Dispersion Formulation and Composition of Physiological Fluid on Micellar and Colloidal Speciation

(M0930-01-05) Investigating Telmisartan Loaded Oral Microparticles Prepared by an Emulsion-Based Approach

(M0930-01-06) Determination of Time-Temperature-Transformation Curve for Sulfonyl Urea Analogues in the Presence of a Crystallization Inhibitor using Simultaneous XRD-DSC

(W0930-03-13) Impact of Film-Coating Excipient Selection on Tablet Performance and Stability

(M0930-03-14) Enhancement of Raloxifene Hydrochloride Bioavailability by Solubility Improvement and Metabolism Inhibition Employing Hot-Melt Extrusion

(T0930-03-15) How to Ensure a Successful Tablet Coating Formulation Development by Using Polyvinyl Alcohol in Combination with Calcium Carbonate to Provide an Alternative to Titanium Dioxide

(M0930-03-15) Novel Fast Track Method for Stability Studies of Amorphous Solid Dispersions via Powder X-ray Diffraction and Vacuum Compression Molding

(W0930-03-15) Understanding the Stabilization Mechanism of Polyvinyl Alcohols (Parteck® MXP) in ASDs by Structure-Related Properties and PC-SAFT Modeling

(W0930-03-16) Comparison of Dialysis and USP-4 Methods to Differentiate Drug Release from Mesalamine Rectal Suppositories

(T0930-03-16) Investigating the Synergistic Effect of Polymethacrylates and HPC as Polymeric Carrier for Drug Solubility Enhancement

(M0930-03-17) Study of High Dose Vitamin C (1000 mg) ER Hydrophilic Matrix Tablet using METHOCEL™ as the Rate Controlling Polymer

(W0930-04-20) Comparative Investigation of Albendazole Amorphous Solid Dispersion Prepared by Supercritical Fluid Technology and Hot Melt Extrusion

(T0930-04-20) Hansen Solubility Parameters Estimates of Amorphous Dispersion Behavior Are Accurate in Some Cases but Often Inconclusive

(M0930-04-21) Dual Functionality of Bile Acid: Physical Stabilization of Drugs in the Amorphous State and Solubility Enhancement in Solution

(T0930-04-21) Role of Drug–Polymer Interactions and Polymer Concentration on Critical Cooling Rate during Hot-Melt Extrusion of Amorphous Solid Dispersions

(W0930-07-40) In Vivo Evaluation of Bexarotene Oral Microparticles in Beagle Dogs

(T0930-07-40) Tunable Drug Release from Fused Deposition Modelling (FDM) 3D Printed Tablets Fabricated Using a Novel Extrudable Polymer

(T0930-07-41) Development of Scalable and Inhaled Nintedanib-Loaded Polymeric Nanoparticles for Localized Therapy of Idiopathic Pulmonary Fibrosis

(W0930-07-41) Nanosuspension Organic Phase Instead of Solution Water Phase: A New Approach to Loading Hydrophilic Trivalent Arsenic Salt with Hydrophobic Polymer

(M0930-07-41) Surface-Modified Inhalable Microparticle-Encapsulated Triterpenoid for Enhanced Efficacy in Malignant Mesothelioma

(T0930-12-67) Glimepiride Releases from Laboratory Compounded and Two Commercial Tablets Using a Proposed Three Stage In Vitro Dissolution Study

(W0930-12-68) Development and In Vivo Testing of an Enteric Oral Dosage Form of an Amorphous Solid Dispersion in Beagle Dogs that Generates Amorphous Nanoparticles during Dissolution

(M0930-12-70) Amorphous Lactose Solid Dispersion Co-Spray Dried with Magnesium Stearate as a Novel Lactose Carrier

(T1030-01-02) N-nitrosodimethylamine and Dissolution Assessment of Commercial Metformin Products in In-Use Stability Testing

(T1030-01-03) Development and Characterization of Multi-layer Self-Nanoemulsifying Pellets Using Fluid Bed Coating Technique to Enhance the Dissolution and Stability of Ramipril

(M1030-01-05) Intrinsic Dissolution of New Pharmaceutical Film Coating Systems

(W1030-01-05) On Dose Authentication Using Molecular Taggants Applied in a Clear Film Coat

(M1030-01-06) Development of a Child-Friendly Antibiotic Packed Multiparticulate Oral Sprinkle Formulation for Tuberculosis Pharmacotherapy

(M1030-03-13) Employing Hot-Melt Extrusion Technology to Enhance the Solubility of Cannabidiol (CBD)

(W1030-03-16) Comparative Analysis of ‘All-in-One’ Co-processed Excipient Versus Its Proportional Individual Blend in the Production of Vardenafil HCl Tablets via Direction Compression

(M1030-03-16) Investigation of Thermoelastic Properties of a Novel Extrudable Polymer Poly-2-ethyl-tetra-oxazoline (PETOX) for the Development of Amorphous Solid Dispersions by Hot Melt Extrusion

(T1030-03-16) Research of Powder Properties of Microcrystalline Cellulose Grades Desirable for Direct Continuous Compression System

(W1030-03-17) Novel Screening Tool for Predicting Mechanical Properties of Filaments Processed via Hot Melt Extrusion

(M1030-03-17) Spray Drying of Amorphous Solid Dispersions (ASDs): Small Scale Screening of Batches containing Less than 50 mg API

(T1030-03-18) Drug and Colloidal Characteristics Impact the Unstirred Water Layer Thickness

(W1030-03-18) Palatable Tamoxifen Rodent Diet: An Innovative Administration Method in Mice to Achieve Inducible Cre Recombinase

(T1030-04-19) Formulation Development of Dietary Supplements and Stability Prediction Using Accelerated Stability Assessment Program

(W1030-04-19) Inhalable Dry Powder Formulation of PLGA Microparticles Loaded with Clofazimine for Treatment of Tuberculosis

(W1030-04-21) Design of Amorphous Solid Dispersions for the Synchronized Release of Two Drugs

(M1030-04-22) Control of Recrystallization in Tablets Containing Amorphous Solid Dispersion

(M1030-04-23) Use of Mega Beads in Designing a Single Unit Biphasic Dosage Form

(M1030-04-24) Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia

(M1030-07-37) Taste Optimization in Oral Dosage Forms: A Sensory Panel Study with the Focus on High-Intensity Sweeteners

(M1030-07-38) Development of Lipid Formulation for Oral Delivery of Proteins and Peptides with Poor Permeability

(M1030-07-39) Days or Centuries? Predicting the Shelf-Life of ASDs

(T1030-07-40) Delivering Smarter Medicines with On-Dose Microtaggants and Smartphone Technology

(W1030-07-40) Screening Primary Parameters Affecting Formulation of Hydrogen Sulfide Donors-Loaded Microparticles using Quality-by-Design (QbD) Approach

(M1030-07-41) Biorelevant Dissolution Method Considerations for the Appropriate Evaluation of Amorphous Solid Dispersions: Are Two Stages Necessary?

(W1030-07-41) Enhanced Oral Bioavailability of Resveratrol Using Various Formulation Strategies

(T1030-07-41) Understanding the Role of Phase Separation in Dissolution of Amorphous Solid Dispersions (ASDs)

(T1030-07-42) Fabrication of Controlled Release Dosages via Selective Laser Sintering Three-Dimensional (3D) Printing Technology

(W1030-07-42) Long-Term Stability Studies of Extemporaneously Compounded Amiloride Nasal Spray

(T1030-12-68) Applications of Deep Learning to Predict Aerosol Performance of Dry Powders for Inhalation

(T1030-12-69) Development of Amorphous Solid Dispersion of Aprepitant Using Sucrose Acetate iso butyrate for Dissolution and Bioavailability Enhancement

(W1030-12-69) Optimization of Amorphization Kinetics during Hot Melt Extrusion by Particle Engineering

(W1030-12-70) A Rheological Approach for Determining Miscibility of Amorphous Solid Dispersions

(M1030-12-70) Solubility Enhancement of BCS Class IV Drug Acyclovir Using Hot Melt Extrusion

(W1030-12-71) Application of Sodium Alginate as Raft-Forming Agent in Anti-reflux Chewable Tablets

(M1030-12-71) Equilibrium Solubility and Solute-Solvent Interactions of Four Drugs in Mono-Solvents

(M1030-12-72) Enhancement of Crystal Nucleation at a Liquid/Vapor Interface

(T1030-12-72) Pharmaceutical Formulation and In Vitro Analyses of a Paediatric Fixed-Dose Combination Antimycobacterial Reconstitutable Oral Suspension

(M1130-01-02) Impact of Granulation Solvent on Release Performance of Dual Matrix Extended-Release Tablets of Highly Water-Soluble Drugs Formulated Using Compritol^®888ATO and Methocel^® as Release Retarding Agents

(M1130-01-03) Using Design of Experiments (DoE) in Validation of Camo-peg NL Formulation

(T1130-01-05) Recent Advances in ASD Formulations: HIPROS and Dispersome

(W1130-01-06) Amorphous Chemical Stability of an Oral Tablet Using Moisture-Modified Arrhenius Modeling

(T1130-01-06) Eliminating Upper Gastrointestinal Irritation of a Novel Therapeutic (SCTL-007) by Developing Modified Release Matrix Tablets Utilizing HPMC Polymers

(T1130-03-13) Mechanical Properties of Reinforced Polyvinyl Alcohol Cryogels

(W1130-03-14) Development and Evaluation of a Label Friendly Film Coating System Containing Naturally Derived Opacifier

(T1130-03-16) Thermodynamic Phase Diagrams for Predicting Drug-Polymer Miscibility of High Melting Point Drugs with Poly-2-ethyl-tetra-oxazoline for Development of Amorphous Solid Dispersions

(T1130-03-17) Kinetic Barriers to Disproportionation of Salts of Weakly Basic Drugs

(M1130-03-18) Developing In Vitro Lipolysis Model for Real-Time Analysis of Drug Concentrations during Digestion of Lipid-Based Formulations

(T1130-03-18) Impact of Coating Process Parameters on Drug Layering of Sitagliptin over Metformin HCl ER Tablets

(M1130-04-22) Anticancer Activity and Pulmonary Delivery of an Antimicrobial Peptide, Nisin ZP, for Non-Small Cell Lung Cancer (NSCLC) Treatment

(T1130-04-22) Preparation and Evaluation of 2D Printing Controlled Release Film Containing Fine Dose Theophylline

(W1130-04-22) Preparation and Evaluation of Choline Alfoscerate Sustained Release Coated Soft Capsule Using the Controlled Osmotic Pump System

(T1130-04-23) Development of a Low-Dose Pilocarpine Ophthalmic Formulation that is Stable, Well-Tolerated and Bioavailable at a Near-Neutral pH for the Treatment of Presbyopia

(W1130-04-23) The Effect of Surfactants and pH Modifying Agents on the Dissolution and Permeation of Pimobendan

(T1130-04-24) A Potential Mechanism of Tabletability Flip Phenomenon

(W1130-04-24) Evaluation of Polymers for Extended-Release Formulations: Hot-Melt Extrusion Paired Fused Deposition Modeling 3D Printing

(T1130-07-37) Can an Excipient System including Magnesium Stearate Resist Mixing Times?

(W1130-07-38) Investigation of Physical Stability of Coamorphous Systems at Elevated Temperature and Humidity Conditions

(T1130-07-38) The Influence of the Chiral Coformer Tryptophan on the Physical Stability of Co-amorphous Systems with Indomethacin as Model Drug

(M1130-07-40) The Effects of 3D-Printing Polyhedron Mini-tablets and Their Drug Delivery Kinetic Models

(M1130-07-41) Optimization of Novel Platinum Based Cyanide Scavengers: In Vitro Prioritization

(M1130-07-42) Fabrication of a Core-Shell Model for Combinational Drug Delivery via Hot Melt-Extrusion Paired with 3D Printing

(M1130-12-67) Anti-SARS-CoV-2 Nasal Powders: Manufacturing, Ex Vivo Drug Accumulation/Transport in Rabbit Nasal Mucosa and In Vitro Virus Inhibition

(T1130-12-70) Development and Evaluation of Polyvinylpyrrolidone and Chitosan-Based Film Forming Gel containing Acyclovir

(W1130-12-70) Development of a Donepezil Dry Powder Formulation for Enhanced Nasal Mucosa Permeation

(W1130-12-71) A Preclinical Solution Formulation Development with the Fundamental Understanding of Salt Solubility

(W1130-12-72) In Vitro Evaluation of an Extended Released Methylphenidate Hydrochloride Product Sprinkled on Food Vehicles

(T1130-12-72) Structures of Glasses Created by Multiple Kinetic Arrests

(T1230-01-01) Developing a Stable Model Formulation to be Used as a Platform Technology for BCS Class II and IV Hydrophobic Molecules with Log P >3 while Using an Aprotic Solvent System as a Solubilizer and Carrier

(T1230-01-03) Identification of Critical Spray-Drying Process Parameters for Preparing Size Tunable Microparticles using Polyvinyl Pyrrolidone and Sodium Alginate

(T1230-01-04) Enteric Coating of an Amorphous Solid Dispersion: An Emerging Strategy to Enhance the Dissolution Performance in Stimulated Gastrointestinal Fluids

(T1230-01-05) Charcoal Drug Adsorption Efficiency in Various Solvents

(M1230-01-05) Digital Light Processing (DLP) 3D Printed Tablets and Its Pharmacokinetic Evaluation in Rats

(W1230-01-05) Early-Stage Polymer Selection in Development of Stable Amorphous Solid Dispersion by Integrating Molecular Dynamics Simulation and Experimental Techniques

(M1230-03-13) A Heat-Shielded Abuse Deterrent Formulation

(T1230-03-16) How to Improve in Solubility of Water-Insoluble Cyclic Peptide with HA Nanogel : Over 100,000-Fold Solubilization

(T1230-03-18) Development of a UV Imaging Method for Characterization of Intra-Tumoral Injectables Using cAMP as Model Substance

(T1230-04-19) Insights into the Impact of Interplay of Drug Loading and Buffer Capacity on the Release of Hydroxypropyl Methyl Cellulose Acetate Succinate (HPMCAS)-Based Dispersions

(T1230-04-21) In Vitro Cytotoxicity and Biodistribution Study of Oxaliplatin-Loaded Multivesicular Liposomal Depot

(M1230-04-22) Food Effect Risk Assessment in Preformulation Stage Using Material Sparing µFLUX Methodology

(M1230-04-23) Formulation Design, Characterisation and In Vivo Performance of Self-Emulsifying Drug Delivery Systems (SEDDS) for a BSC Class II NCE

(M1230-04-24) Comparison of Mucociliary Clearance Rates of Bioadhesive Gels, Powders and Spray-Dried Polymeric Microparticles

(M1230-07-38) Assessing the Interrelationship of Microstructure, Properties, Drug Release Performance, and Preparation Process for Amorphous Solid Dispersions

(T1230-07-39) Application of Film Coating Systems to Hide Dark Spots on Multivitamin Tablets

(M1230-07-39) Impact of Modulating HPMC Properties on Modified Released Matrix Formulation of a High Dose Drug

(T1230-07-40) Investigation of the Impact of Manufacturing Parameters on the Mechanism of Formation of Naltrexone-PLGA Microparticles with SSNMR

(W1230-07-40) Preparation of Highly Soluble Anti-tubercular Salt: Clofazimine mesylate

(T1230-07-41) How to Maintain Drug Stability During Twin-Screw Melt Granulation

(W1230-07-41) Solubility Measurement and Modeling of Various Drugs in Binary Solvent Mixtures at Different Temperatures

(T1230-12-69) Impact of Aluminum Oxide Nanocoating on Release Behavior of Posaconazole/HPMCAS Amorphous Solid Dispersions

(M1230-12-70) Cyclodextrin Inclusion Complex of Novel Anti-mycobacterial Compound

(T1230-12-71) pH Impact on the Suspension Capability of Colloidal MCC

(M1230-12-72) Optimizing the Synthesis and Performance of Amorphous Drug-Polymer Salts through Acid-Base Reactions: an X-ray Photoelectron Spectroscopy Study

(M1330-01-03) Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design Approach

(T1330-01-05) Augmenting In Vitro Dissolution of a Poorly Soluble API with a Multifunctional Lipidic Surfactant in an Orally Disintegrating Tablet

(M1330-01-05) Creation and Utilization of Polymer “Alloys” to Increase Drug Loading and Dissolution Performance of Ivacaftor Amorphous Solid Dispersion

(T1330-01-06) Scaled-Up Production of High Drug Loading and Dissolution Enabling Lumefantrine Granules

(T1330-03-14) Study on the Impact of Tablet Compression Parameters for a Directly Compressible Formulation Containing Model Low Dose API

(M1330-03-16) pH-Independent Modified Release Matrix Tablet of Weakly Basic Drug Using Acidic Ionizable Polymer

(M1330-03-17) Alternative Methotrexate Oral Formulation: Enhanced Aqueous Solubility, Bioavailability, Photostability, and Permeability

(M1330-03-18) Study of the Physiochemical Characteristics of Luteolin for Application in (Trans)Dermal Delivery

(M1330-04-19) Mechanistic Understanding of the Impact of Ionic Interactions between Drug and Polymer on HPMCAS-Based Amorphous Solid Dispersion Performance

(T1330-04-22) N-acetylcysteine-Loaded Magnetite Chitosan Microparticle (NMCP) Part Ⅱ: In Vitro and In Vivo Study to Confirm the Nitrate Adsorption Behavior

(T1330-04-23) Amorphous Powder for Nasal Delivery: Intranasal Naloxone Powder for Treating Opiod Overdose

(T1330-04-24) Preparation and Characterization of a New Sweet Salt of Berberine

(T1330-07-37) Coexistent API-Polymer Halogen and Hydrogen Bonds in Amorphous Solid Dispersions Affect Drug Solubility and Miscibility

(T1330-07-39) Influence of Solid Content and Plasticizer in Formulation of Hypromellose Oral Thin Film – Part 1

(M1330-07-40) Enteric Coating and Evaluation of Optimized Curcumin-Loaded Nanostructured Lipid Carriers

(M1330-07-41) Improving Dissolution Performance and Drug Loading of Amorphous Dispersions Through a Hierarchical Particle Approach

(M1330-07-42) Development of a Theranostic Agent for Potential Diagnosis and Treatment of High-Risk Neuroblastoma in Children

(M1330-12-69) Development of Nicotine Dry Powder for Inhalation by Thin-Film Freezing

(T1330-12-70) API-Sparing KinetiSol Processing Approach to Support Discovery Chemistry

(M1330-12-71) Application of Avicel® as Cushioning Agent in MUPS Tablets

(T1330-12-71) Quality and Processability Parameters Prediction for a Direct Compressible Tablet Powder Mix

(T1330-12-72) Investigation of Polymers for SLS 3D-Printing of Solid Oral Dosage Forms

(T1430-01-01) Development of Sublingual Tablets Containing Promethazine Hydrochloride for Paediatric Applications

(T1430-01-04) Animal Pharmacokinetic Studies of Cannabidiol Nanoformulation

(M1430-01-05) A Systematic Approach to Developing Lipid-Based Drug Delivery Systems (LBDDS) with Fenobrate as Model Drug

(M1430-01-06) Target New Therapeutics Areas from Aspirin while Using Hot Melt Extrusion as an Enabling Technology

(M1430-03-13) Investigation of Factors Influencing Drug Release from Controlled Release Hydrophilic Matrix Formulation using Central Composite Design of Experiments

(M1430-03-14) The Effect of a Clean-Label, Plant-Based Natural Glidant on the Flow Properties of Multiple Model Powders Compared to a Synthetic Glidant

(M1430-03-15) 3D Printing of Container Tablets: A New Paradigm for Multi-drug containing Bioactive Self-Nanoemulsifying Drug Delivery Systems (Bio-SNEDDS)

(T1430-03-16) Comparison of Film Coating Weight, Color Uniformity and Throughput of Tablets Coated in High Speed Semi Continuous Coater and Traditional Pan Coater Using Titanium Dioxide Free Film Coating Systems

(T1430-03-17) The Sustained Release Potential of MCM-41 versus SBA-16 Serving as Entrapment Carriers after Amine Surface Functionalization

(T1430-03-18) Application of MicroCoat^TM Technology to Mask Bitter Taste of Amodiaquine and Artesunate in a Combination Antimalarial Formulation for Oral Paediatric Administration

(M1430-03-18) Super Material-Sparing HME Screening: Simultaneous API Loading and Degradation Predictions

(M1430-04-21) Comparison of the Tendency of DC Excipients to Build-Up of Static Electricity

(M1430-04-22) Determining Critical Parameters that Predict Physical Stability of Amorphous Solid Dispersions

(T1430-04-23) Building a Chemical Space Map for In Silico Prediction of Supersaturation by Mesoporous Silica

(M1430-04-23) Evaluating pH and Buffer Effects on (-)- and (+)- Phenserine Chemical Stability

(M1430-07-37) Development of Inhalable Layer-by-Layer Assembled Particles for Small Cell Lung Cancer (SCLC) Treatment

(M1430-07-39) Treatment of Non-Tuberculous Mycobacterial Infections via Spray Dried Tigecycline Dry Powder Aerosols

(M1430-07-40) Developing Cyclodextrin-Complexed Edaravone – An Inhaled Repurposed Therapy for Idiopathic Pulmonary Fibrosis (IPF)

(T1430-07-40) Preformulation Studies on Two Novel Indole-2-Carboxamides Highly Potent Against Nontuberculous Mycobacteria

(T1430-07-41) Preparation of Telmisartan Nanoparticles by the Supercritical Antisolvent Process: Effect of Particle Size on the Dissolution and Oral Bioavailability

(M1430-07-41) The Size of the Unstirred Water Layer as a Function of Diffusion Coefficient

(T1430-07-42) Preparation and Characterization of Orally Disintegrating Tablets of Caffeine, Verapamil and Atenolol

(T1430-12-68) Inhaled Ponatinib-Cyclodextrin Complex for Anticancer Effects on Non-Small Cell Lung Cancer

(T1430-12-70) Inhaled Albumin Nanoparticles as a Delivery Strategy to Improve the Risk/Benefit Ratio of PDE-4 Inhibitors

(M1430-12-71) Evaluation on Stability of Plant Based Softgels (SeaGel® Technology) versus Gelatin Softgels

(M1530-01-03) In Vitro and In Vivo Characterization of Rapidly Dissolving Printlets of Isoniazid Manufactured by SLS 3D Printing

(T1530-01-05) Pectin as a Natural Tablet Coating Alternative

(T1530-01-06) Properties and Printability of Recycled Pharmaceutical Powder Blend in SLS 3D Printing

(T1530-03-13) Characterization of Swelling Behavior of HPMC alone and in Combination with Some Ionic Polymers

(T1530-03-15) A Comparison of Cocrystals of a Poorly Water-Soluble, Fast Recrystallizing Drug with Its Amorphous Solid Dispersions

(M1530-03-16) An Assessment of the Gastro-Resistance and Dissolution Rate of Banded and Not-Banded Capsules Coated with an Enteric Coating Film

(M1530-03-17) Impacts of Polymer Thermal Degradation on In Vitro Performance of Amorphous Solid Dispersions

(M1530-03-18) Impact of Manufacturing Processes of Supersaturation Optimized Ternary Amorphous Solid Dispersions on Solid State and Dissolution Performance

(M1530-04-19) Solubility Enhancement and Improved Efficacy of Delamanid Using Cyclodextrin Inclusion Complex

(T1530-04-22) N-acetylcysteine-Loaded Magnetite Chitosan Microparticle (NMCP) Part I: Preparation of Inhalable Chitosan-Fe₃O₄ Composite for Removal of Nitrate of Particulate Matter

(T1530-04-23) Determination of Binding Constants between Diflunisal and Trazodone and Several Excipients

(M1530-04-23) Effect of Coacervation Processing Parameters on In Vitro Drug Release from PLGA Microspheres

(T1530-04-24) Compatibility Study between Fluoroquinolones and Carbopol^® Polymers Used in the In Situ Gel Forming Delivery Systems

(T1530-07-38) Synthesizing Cisplatin Pt (IV) Derivatives for Reducing Systemic Toxicity and Enhancing Anticancer Efficacy in Triple-Negative Breast Cancer

(M1530-07-40) Investigation of Nasal Delivery System of a Prokinetic for the Treatment of Gastroparesis and Other Motility Related Disorders

(M1530-07-41) Spray Dried Combination Formulations of Tobramycin and Colistin for Pulmonary Delivery Show Excellent In Vitro Powder Aerosolization

(M1530-07-42) Discovery of a Targeted Oral Prodrug for Prostate Cancer Therapy

(M1530-12-67) Arginine Coated Self-Emulsifying Nanoglobules for Nasal Delivery of Insulin

(T1530-12-70) In Situ Phase Transition to Liquid Crystal with the GMO and Co-surfactant for Controlled Nasal Mucosa Permeation of Drug

(M1530-12-70) Reformulation of Niclosamide into Biofilm Penetrating Nanoparticles to Improve Its Repurposing for the Treatment of Candidiasis

(T1530-12-71) Development of a Fixed Dose Combinations Using Double Melt Extrusion Technology

(T1530-12-72) Dissolution Rate Increases for Morphine Sulfate Extended-Release Drug Product When Mixed with High pH Soft Food for Long Contact Times

(M0930-12-72) Co-processed Hydroxypropyl Methylcellulose–Mannitol as a Directly Compressible Excipient for Controlled Release

(T1130-07-42) Chiral Resolution by Crystallization: The Case of Arabitol

(T1430-04-24) Investigating Critical Parameters for Using Phenylarsine Oxide as a Surrogate to Assess Percutaneous Absorption of Arsenicals